EPCAM and hepatocellular carcinoma: Here, we demonstrate the potential role of BMP9 and its target transcription factor inhibitor of DNA‐binding protein 1 (ID1) in the activation of EpCAM+ CSC properties in HCC, and we demonstrate the effect of BMP receptor inhibitors, which suppress HCC tumor growth by inhibiting BMP9‐ID1 signaling.